Madison Avenue Partners, LP 13D and 13G filings for Keros Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 5:49 pm Purchase | 2025-05-07 | 13G | Keros Therapeutics, Inc. KROS | Madison Avenue Partners, LP | 2,614,402 6.400% | 2,614,402 (New Position) | Filing |